Skip to content

Type: Policy Documents

Improving Medical Decisions Using Comparative Effectiveness Research

Expanding Comparative Effectiveness Research: Priority Areas in Oncology

Despite Criticism Of The FDA Review Process, New Cancer Drugs Reach Patients Sooner In The United States Than In Europe

Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400.

The 21st Century Cures Act